EXFORGE HCT 5/160/12.5MG 14 F.C. TAB

Exforge tablets are formulated in four strengths for oral administration with a combination of amlodipine besylate equivalent to 5 mg or 10 mg of amlodipine free-base with 160 mg or 320 mg of valsartan providing for the following available combinations: 5/160 mg 10/160 mg 5/320 mg and 10/320 mg. Valsartan is a nonpeptide orally active and specific angiotensin II antagonist acting on the AT1 receptor subtype. (amlodipine and valsartan) is indicated for the treatment of hypertension to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine and the ARB class to which valsartan principally belongs. There are no controlled trials demonstrating risk reduction with Exforge.